Visual BCIs based on steady-state visual evoked potentials (SSVEPs) have long been the gold standard for high-speed noninvasive brain-computer ...

This study presents valuable findings by reanalyzing previously published MEG and ECoG datasets to challenge the predictive nature of pre-onset neural encoding effects. The evidence supporting the ...

A Mirai botnet has started exploiting CVE-2025-29635, a year-old command injection vulnerability in discontinued D-Link ...

Wayfinder Biosciences, a biotechnology company using small molecules to target undruggable proteins at the RNA level, today ...

Here's why the C-suite needs to understand entity engineering as a corporate asset, not a digital marketing tactic.

Self-propagating npm worm steals tokens via postinstall hooks, impacting six packages and expanding supply chain attacks.

The alternative text for this image may have been generated using AI. Figure 2: Regulation of the TGFBR2 promoter by EWS-FLI1 and FLI1, and electrophoretic mobility shift assay of in vitro-translated ...

Wayfinder Biosciences, a biotechnology company using small molecules to target undruggable proteins at the RNA level, today ...

If confirmed by the European Commission, REDEMPLO would be the first and only siRNA medicine authorized in the EU for both genetically confirmed and clinically diagnosed adult patients with FCS– ...

Spearheaded by patient-scientist Sonia Vallabh and Eric Minikel at the Broad Institute, a new drug candidate designed to slow the progression of prion disease is entering a phase 1 clinical trial, ...